Search

Subject ALK -- ceritinib -- crizotinib -- NSCLC

1. Front‐line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control. Issue 12 (15th October 2019)

Authors:
Huang, Shih‐Hao; Huang, Allen Chung‐Cheng; Wang, Chin‐Chou; Chang, Wen‐Chen; Liu, Chien‐Ying; Pavlidis, Stelios; Ko, Ho‐Wen; Chung, Fu‐Tsai; Hsu, Ping‐Chih; Guo, Yi‐Ke; Kuo, Chih‐Hsi Scott; Yang, Cheng‐Ta
Journal:
Thoracic cancer
Issue:
Volume 10:Issue 12(2019)
Page Start:
2274
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • ALK -- ceritinib -- crizotinib -- NSCLC 1